4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000037
CEO bought 34,000 shares at an average $0.01 ($425)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-04 | Purchase : show line 1 in the form | +10,000 | $0.01 | $130 | 24,167,097 | D |
| 2019-06-04 | Purchase : show line 2 in the form | +1,000 | $0.01 | $13 | 24,168,097 | D |
| 2019-06-04 | Purchase : show line 3 in the form | +2,000 | $0.01 | $26 | 24,170,097 | D |
| 2019-06-04 | Purchase : show line 4 in the form | +1,000 | $0.01 | $12 | 24,171,097 | D |
| 2019-06-04 | Purchase : show line 5 in the form | +15,000 | $0.01 | $183 | 24,186,097 | D |
| 2019-06-04 | Purchase : show line 6 in the form | +5,000 | $0.01 | $62 | 24,191,097 | D |
| Open-market purchases · 34,000 sh · avg $0.01 · $425 | ||||||
Loading xslF345X03/primary_doc.xml…